DRIO DarioHealth Corporation: Net earnings per share growth forecast for next year

DarioHealth Corp. (DRIO) possesses significant pricing power due to the integration of smart glucometers with an AI coach for hypertension management. The projected 12-month EPS trajectory reflects market expectations, with the indicator settling at 34.50. The ecosystem of sensors and applications ensures stable subscription revenue. An impeccable image and corporate client loyalty confirm the company's leadership in digital medicine.

DRIO: DarioHealth Corp Expected earnings per share trend next year 07/04/2022 - 11/15/2026

Analytical breakdowns and data insights for company DarioHealth Corp (DRIO)

- share price and consensus valuation forecast:

Stock Price mydario.com|DRIO - Analyst Median Target

- company stock capitalization data:

Market Value DarioHealth|DRIO - Total Enterprise Value

- company book value details:

Book Value per Share DarioHealth|DRIO - Accounting Value of Company|Market Capitalization to Book Value Ratio mydario.com|DRIO - Company Assets

- issuer credit burden and liquidity indicators:

- earnings and valuation multiples information:

DRIO - Final Profit|Projected Future Earnings DarioHealth Corp.|DRIO - Price to Earnings Ratio|Future Price to Earnings DarioHealth Inc|DRIO - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DarioHealth Corporation|DRIO - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months DarioHealth|DRIO - Earnings per one share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months mydario.com|DRIO - Expected net earnings per share growth this year|Earnings growth forecast for next year DarioHealth Corp.

- sales and revenue indicators:

DRIO - Company Sales Volume|Company Projected Revenue DarioHealth Corp.|DRIO - Market Capitalization-to-Revenue Ratio|Forward P/S Multiple DarioHealth Inc|DRIO - Annual Revenue Growth (Last Twelve Months)

Summary company analysis:DarioHealth Corporation

DarioHealth Corp. (DRIO) aims for dominance in the telemedicine segment through the expansion of b2b2c subscriptions for US insurers. Analyzing the projected EPS growth for the coming year, an investor sees a consensus earnings per share forecast that reflects market expectations for the IT platform's scalability. While inflated forecasts promise high returns, they create the risk of a sharp capital correction if the business fails to meet its target performance metrics.

Direct competitors